Immunohistochemical study of PAX5 expression in lymphoid neoplasms / Wael Abdelfattah Mohamed Ibrahim ; Supervised Ahmed Mohamed Yehia Elhennawy , Samia Mohamed Ahmed Gabal , Mona Salah Eldin Abdelmagid

By:

Wael Abdelfattah Mohamed Ibrahim

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Wael Abdelfattah Mohamed Ibrahim , 2021Description: 212 P . : charts , facsmilies ; 25cmOther title:

دراسة هيستوكيميائية مناعية لتعبير باكس -5 فى الاورام الليمفاوية [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pathology Summary: PAX5 is a monoclonal antibody to a nuclear antigen which is expressed in B lymphocytes, the developing CNS, and adult testis, and can be used on formalin-fixed, paraffin-embedded tissue sections. PAX5 was used in this study to assess the expression of PAX5 gene in 60 cases of lymphoid neoplasms. This study showed that 100% of B cell lymphoma and 90% of classical Hodgkin lymphoma included in this study express PAX5. Thus we concluded that PAX5 can be used as a pan B cell marker and to confirm the B cell origin of most classical Hodgkin lymphoma

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.27.Ph.D.2021.Wa.I (Browse shelf(Opens below))		Not for loan		01010110083362000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.27.Ph.D.2021.Wa.I (Browse shelf(Opens below))	83362.CD	Not for loan		01020110083362000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.27.Ph.D.2021.Al.I Immunohistochemical expression of PDL1 & idh1 & detection of mgmt promoter methylation by PCR in astrocytoma /	Cai01.11.27.Ph.D.2021.Al.I Immunohistochemical expression of PDL1 & idh1 & detection of mgmt promoter methylation by PCR in astrocytoma /	Cai01.11.27.Ph.D.2021.Ma.I Immunohistochemical expression of programmed death ligand 1 (pd-l1) in endometrial carcinoma	Cai01.11.27.Ph.D.2021.Wa.I Immunohistochemical study of PAX5 expression in lymphoid neoplasms /	Cai01.11.27.Ph.D.2021.Wa.I Immunohistochemical study of PAX5 expression in lymphoid neoplasms /	Cai01.11.27.Ph.D.2022.Ma.U. The utility of SMAD4 and S100P as diagnostic immunohistochemical markers forpancreatic ductal adenocarcinomas /	Cai01.11.27.Ph.D.2022.Me.P Prostate-specific membrane antigen (psma) expression in the neovasculature of high grade gliomas /	Next

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pathology

PAX5 is a monoclonal antibody to a nuclear antigen which is expressed in B lymphocytes, the developing CNS, and adult testis, and can be used on formalin-fixed, paraffin-embedded tissue sections. PAX5 was used in this study to assess the expression of PAX5 gene in 60 cases of lymphoid neoplasms. This study showed that 100% of B cell lymphoma and 90% of classical Hodgkin lymphoma included in this study express PAX5. Thus we concluded that PAX5 can be used as a pan B cell marker and to confirm the B cell origin of most classical Hodgkin lymphoma

Issued also as CD

There are no comments on this title.

to post a comment.